Clinical Trials List
2021-08-01 - 2028-01-30
Phase III
Not yet recruiting4
Recruiting3
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yeong-Shiau Pu Division of Urology
- YI-KAI CHANG Division of Urology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 王中傑 Division of Others
- PO-MING CHOW Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- YEN-HENG LIN Division of Radiology
- - - Division of Urology
- JIAN-HUA HONG Division of Urology
- FU-JEN HSUEH Division of Hematology & Oncology
- CHUNG-HSIN CHEN Division of Urology
- Ying-Chun Shen Division of Hematology & Oncology
- CHING-CHU LU Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Che-Yuan Hu Division of Urology
- Jiann-Hui Ou Division of Urology
- Yuh-Shyan Tsai Division of Urology
- 楊舜如 Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Rita cheng Division of Urology
- I-hung Shao Division of Urology
- 黃文冠 Division of Hematology & Oncology
- 陳東藝 Division of Cardiovascular Diseases
- 林柏宏 未分科
- Ming-Li Hsieh Division of Urology
- 張鈞弼 Division of Radiology
- Hong-Cheng Gan Division of Urology
- Kai-Jie Yu Division of Urology
- Yung-Chang Lin Division of Hematology & Oncology
- PO-HUNG LIN Division of Urology
- Yuan-Cheng Chu Division of Urology
- 黃亮鋼 Division of Urology
- Po-Jung Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 黃俊農 未分科
- 李政學 未分科
- Hung-Lung Ke 未分科
- Tsu-Ming Chien 未分科
- Ching-Chia Li 未分科
- Sheng-Chen Wen 未分科
- Hsiang Ying Lee 未分科
- 阮雍順 未分科
- Tsung-Yi Huang 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
63 participants
-
Global
804 participants
